| Time |
Lecture |
Speaker |
| 08:30 |
Opening Ceremony, Introduction
Atherothrombotic Cardiovascular Disease
From lipids and other risk factors to „post MI“ complications
|
Prof. R. Češka (CZ) |
|
Block I. Atherosclerosis/Guidelines |
|
| 9:00 |
Atherosclerosis and cardiovascular system |
Dr. Lansberg (NL) |
| 9:45 |
2019 ESC/EAS Guidelines for the management of dyslipidaemias |
Prof. A. Zambon (IT) |
| |
|
|
| 10:30 |
Interactive discussion/slido |
|
| 10:45 |
Break |
|
|
Block II. Risk factors of CVD |
|
| 11:00 |
ESC/ESH guidelines for management of hypertension |
Prof. Cífková (CZ) |
| 11:30 |
Cardiovascular Risk Factors-Complex approach is needed |
Prof. R. Češka (CZ) |
| 12:00 |
Drug combination in cardiology, Adherence |
Prof. K. Narkiewicz (PL) |
| 12:30 |
Interactive discussion/slido |
|
| 13:00 |
Lunch |
|
|
Block III. Myocardial infarction – lessons from Cath Lab |
|
| 13:30 |
ESC Guidelines for the management of acute myocardial infarction,
Recent advances in the diagnosis and treatment of acute myocardial infarction |
Prof. Vinereanu (RO) |
| 14:00 |
The role of echocardiography in acute myocardial infarction/video demonstration
|
Prof. K. Trusinskis (LV) |
| 14:30 |
Role of intervention in/after myocardial infarction/video demonstration |
Doc. Kovárník (CZ) |
| 15:00 |
Interactive discussion/slido |
|
| 15:15 |
Break |
|
|
Block IV. Generics/ Pharmacoeconomics |
|
| 15:30 |
Current and future trends in the use of generic medicines in Europe |
Dr. J. Skoupá (CZ) |
| 16:00 |
Workshop |
Dr. J. Skoupá (CZ) |
